Summary
The global Parkinson's Disease Drug market is expected to reach xxx Million USD by 2025, with a CAGR of xx% from 2020 to 2025.
Further key aspects of the report indicate that:
Chapter 1: Market Definition and Segment by Type, End-Use & Major Regions Market Size
Chapter 2: Global Production & Consumption Market by Type and End-Use
Chapter 3: Europe Production & Consumption Market by Type and End-Use
Chapter 4: America Production & Consumption Market by Type and End-Use
Chapter 5: Asia Production & Consumption Market by Type and End-Use
Chapter 6: Oceania Production & Consumption Market by Type and End-Use
Chapter 7: Africa Production & Consumption Market by Type and End-Use
Chapter 8: Global Market Forecast by Type, End-Use and Region
Chapter 9: Company information, Sales, Cost, Margin, news etc.
Chapter 10: Market Competition by Companies and Market Concentration Ratio
Chapter 11: Market Impact by Coronavirus.
Chapter 12: Industry Summary
Market Segment as follows:
Key Companies
- Merck
- Akorn
- GSK
- Novartis
- Boehringer Ingelheim
- Teva Pharmaceutical
- Abbvie
- Kyowa Hakko Kirin Pharma
- Astellas Pharma
- Desitin Arzneimittel
- Endo Pharmaceuticals
- F.Hoffmann-La Roche
- H.Lundbeck
- Valeant
- Apokyn
- Orion
- Stada Arzneimittel
- US WorldMeds
- Valeant Pharmaceuticals
Key Types
- Sinemet-CR
- Trastal
- Madopar
- COMT Inhibitor
- Others
Key End-Use
- Under 40 Years Old
- 40-65 Years Old
- Above 65 Years Old
This report can be dispatched within 24-48 Hours.
2015-2025 Global Parkinson's Disease Drug Market Research by Type, End-Use and Region (COVID-19)
Table of Contents
CHAPTER 1 MARKET OVERVIEW
1.1 Market Definition and Segment
1.1.1 Product Definition
1.1.2 Product Type
1.1.3 End-Use
1.1.4 Marketing Channel
1.2 Major Regions
1.2.1 Europe Market Size and Growth
Figure Europe Parkinson's Disease Drug Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Europe Parkinson's Disease Drug Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.2 America Market Size and Growth
Figure America Parkinson's Disease Drug Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure America Parkinson's Disease Drug Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.3 Asia Market Size and Growth
Figure Asia Parkinson's Disease Drug Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure AsiaParkinson's Disease Drug Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.4 Oceania Market Size and Growth
Figure Oceania Parkinson's Disease Drug Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Oceania Parkinson's Disease Drug Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.5 Africa Market Size and Growth
Figure Africa Parkinson's Disease Drug Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Africa Parkinson's Disease Drug Market Forecast and Growth Rate, 2020E-2025F (Million USD)
CHAPTER 2 GLOBAL MARKET SEGMENTATION
2.1 Global Production Overview
Table Global Parkinson's Disease Drug Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
2.2 Global Consumption Overview
Table Global Parkinson's Disease Drug Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
2.3 Global Production by Type
Table Global Parkinson's Disease Drug Revenue by Type, 2015-2020 (Million USD)
Figure Global Parkinson's Disease Drug Revenue Share by Type in 2020 (Million USD)
Table Global Parkinson's Disease Drug Production Volume by Type, 2015-2020 (Volume)
Figure Global Parkinson's Disease Drug Production Volume Share by Type in 2020 (Volume)
2.4 Global Consumption by End-Use
Table Global Parkinson's Disease Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Global Parkinson's Disease Drug Consumption Value Share by End-Use in 2020 (Million USD)
Table Global Parkinson's Disease Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Global Parkinson's Disease Drug Consumption Volume Share by End-Use in 2020 (Volume)
2.5 Global Consumption by Region
Table Global Parkinson's Disease Drug Consumption Value by Region, 2015-2020 (Million USD)
Table Global Parkinson's Disease Drug Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 3 Europe MARKET SEGMENTATION
3.1 Europe Production Overview
Table Europe Parkinson's Disease Drug Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
3.2 Europe Consumption Overview
Table Europe Parkinson's Disease Drug Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
3.3 Europe Production by Type
Table Europe Parkinson's Disease Drug Revenue by Type, 2015-2020 (Million USD)
Figure Europe Parkinson's Disease Drug Revenue Share by Type in 2020 (Million USD)
Table Europe Parkinson's Disease Drug Production Volume by Type, 2015-2020 (Volume)
Figure Europe Parkinson's Disease Drug Production Volume Share by Type in 2020 (Volume)
3.4 Europe Consumption by End-Use
Table Europe Parkinson's Disease Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Europe Parkinson's Disease Drug Consumption Value Share by End-Use in 2020 (Million USD)
Table Europe Parkinson's Disease Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Europe Parkinson's Disease Drug Consumption Volume Share by End-Use in 2020 (Volume)
3.5 Europe Consumption by Region
Table Europe Parkinson's Disease Drug Consumption Value by Region, 2015-2020 (Million USD)
Table Europe Parkinson's Disease Drug Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 4 AMERICA MARKET SEGMENTATION
4.1 America Production Overview
Table America Parkinson's Disease Drug Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
4.2 America Consumption Overview
Table America Parkinson's Disease Drug Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
4.3 America Production by Type
Table America Parkinson's Disease Drug Revenue by Type, 2015-2020 (Million USD)
Figure America Parkinson's Disease Drug Revenue Share by Type in 2020 (Million USD)
Table America Parkinson's Disease Drug Production Volume by Type, 2015-2020 (Volume)
Figure America Parkinson's Disease Drug Production Volume Share by Type in 2020 (Volume)
4.4 America Consumption by End-Use
Table America Parkinson's Disease Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Figure America Parkinson's Disease Drug Consumption Value Share by End-Use in 2020 (Million USD)
Table America Parkinson's Disease Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Figure America Parkinson's Disease Drug Consumption Volume Share by End-Use in 2020 (Volume)
4.5 America Consumption by Region
Table America Parkinson's Disease Drug Consumption Value by Region, 2015-2020 (Million USD)
Table America Parkinson's Disease Drug Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 5 ASIA MARKET SEGMENTATION
5.1 Asia Production Overview
Table Asia Parkinson's Disease Drug Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
5.2 Asia Consumption Overview
Table Asia Parkinson's Disease Drug Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
5.3 Asia Production by Type
Table Asia Parkinson's Disease Drug Revenue by Type, 2015-2020 (Million USD)
Figure Asia Parkinson's Disease Drug Revenue Share by Type in 2020 (Million USD)
Table Asia Parkinson's Disease Drug Production Volume by Type, 2015-2020 (Volume)
Figure Asia Parkinson's Disease Drug Production Volume Share by Type in 2020 (Volume)
5.4 Asia Consumption by End-Use
Table Asia Parkinson's Disease Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Asia Parkinson's Disease Drug Consumption Value Share by End-Use in 2020 (Million USD)
Table Asia Parkinson's Disease Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Asia Parkinson's Disease Drug Consumption Volume Share by End-Use in 2020 (Volume)
5.5 Asia Consumption by Region
Table Asia Parkinson's Disease Drug Consumption Value by Region, 2015-2020 (Million USD)
Table Asia Parkinson's Disease Drug Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 6 OCEANIA MARKET SEGMENTATION
6.1 Oceania Production Overview
Table Oceania Parkinson's Disease Drug Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
6.2 Oceania Consumption Overview
Table Oceania Parkinson's Disease Drug Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
6.3 Oceania Production by Type
Table Oceania Parkinson's Disease Drug Revenue by Type, 2015-2020 (Million USD)
Figure Oceania Parkinson's Disease Drug Revenue Share by Type in 2020 (Million USD)
Table Oceania Parkinson's Disease Drug Production Volume by Type, 2015-2020 (Volume)
Figure Oceania Parkinson's Disease Drug Production Volume Share by Type in 2020 (Volume)
6.4 Oceania Consumption by End-Use
Table Oceania Parkinson's Disease Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Oceania Parkinson's Disease Drug Consumption Value Share by End-Use in 2020 (Million USD)
Table Oceania Parkinson's Disease Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Oceania Parkinson's Disease Drug Consumption Volume Share by End-Use in 2020 (Volume)
6.5 Oceania Consumption by Region
Table Oceania Parkinson's Disease Drug Consumption Value by Region, 2015-2020 (Million USD)
Table Oceania Parkinson's Disease Drug Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 7 AFRICA MARKET SEGMENTATION
7.1 Africa Production Overview
Table Africa Parkinson's Disease Drug Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
7.2 Africa Consumption Overview
Table Africa Parkinson's Disease Drug Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
7.3 Africa Production by Type
Table Africa Parkinson's Disease Drug Revenue by Type, 2015-2020 (Million USD)
Figure Africa Parkinson's Disease Drug Revenue Share by Type in 2020 (Million USD)
Table Africa Parkinson's Disease Drug Production Volume by Type, 2015-2020 (Volume)
Figure Africa Parkinson's Disease Drug Production Volume Share by Type in 2020 (Volume)
7.4 Africa Consumption by End-Use
Table Africa Parkinson's Disease Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Africa Parkinson's Disease Drug Consumption Value Share by End-Use in 2020 (Million USD)
Table Africa Parkinson's Disease Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Africa Parkinson's Disease Drug Consumption Volume Share by End-Use in 2020 (Volume)
7.5 Africa Consumption by Region
Table Africa Parkinson's Disease Drug Consumption Value by Region, 2015-2020 (Million USD)
Table Africa Parkinson's Disease Drug Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 8 GLOBAL MARKET FORECAST
8.1 Global Parkinson's Disease Drug Production Forecast
Figure Global Parkinson's Disease Drug Revenue and Growth Rate Forecast 2020E-2025F (Million USD)
Figure Global Parkinson's Disease Drug Production Volume and Growth Rate Forecast 2020E-2025F (Volume)
8.2 Global Parkinson's Disease Drug Forecast by Type
Table Global Parkinson's Disease Drug Revenue by Type, 2020E-2025F (Million USD)
Figure Global Parkinson's Disease Drug Revenue Share by Type in 2025 (Million USD)
Table Global Parkinson's Disease Drug Production Volume by Type, 2020E-2025F (Volume)
Figure Global Parkinson's Disease Drug Production Volume Share by Type in 2025 (Volume)
8.3 Global Parkinson's Disease Drug Forecast by End-Use (2020E-2025F)
Table Global Parkinson's Disease Drug Consumption Value by End-Use, 2020E-2025F (Million USD)
Figure Global Parkinson's Disease Drug Consumption Value Share by End-Use in 2025 (Million USD)
Table Global Parkinson's Disease Drug Consumption Volume by End-Use, 2020E-2025F (Volume)
8.4 Global Parkinson's Disease Drug Forecast by Region (2020E-2025F)
Table Global Parkinson's Disease Drug Consumption Value by Region, 2020E-2025F (Million USD)
Figure Global Parkinson's Disease Drug Consumption Value Share by Region in 2025 (Million USD)
Table Global Parkinson's Disease Drug Consumption Volume by Region, 2020E-2025F (Volume)
Figure Global Parkinson's Disease Drug Consumption Volume Share by Region in 2025 (Volume)
CHAPTER 9 GLOBAL MAJOR COMPANIES LIST
9.1 Merck
9.1.1 Merck Profile
Table Merck Overview List
9.1.2 Merck Products & Services
9.1.3 Merck Company Dynamics & News
9.1.4 Merck Business Operation Conditions
Table Business Operation of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.2 Akorn
9.2.1 Akorn Profile
Table Akorn Overview List
9.2.2 Akorn Products & Services
9.2.3 Akorn Company Dynamics & News
9.2.4 Akorn Business Operation Conditions
Table Business Operation of Akorn (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.3 GSK
9.3.1 GSK Profile
Table GSK Overview List
9.3.2 GSK Products & Services
9.3.3 GSK Company Dynamics & News
9.3.4 GSK Business Operation Conditions
Table Business Operation of GSK (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.4 Novartis
9.4.1 Novartis Profile
Table Novartis Overview List
9.4.2 Novartis Products & Services
9.4.3 Novartis Company Dynamics & News
9.4.4 Novartis Business Operation Conditions
Table Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.5 Boehringer Ingelheim
9.5.1 Boehringer Ingelheim Profile
Table Boehringer Ingelheim Overview List
9.5.2 Boehringer Ingelheim Products & Services
9.5.3 Boehringer Ingelheim Company Dynamics & News
9.5.4 Boehringer Ingelheim Business Operation Conditions
Table Business Operation of Boehringer Ingelheim (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.6 Teva Pharmaceutical
9.6.1 Teva Pharmaceutical Profile
Table Teva Pharmaceutical Overview List
9.6.2 Teva Pharmaceutical Products & Services
9.6.3 Teva Pharmaceutical Company Dynamics & News
9.6.4 Teva Pharmaceutical Business Operation Conditions
Table Business Operation of Teva Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.7 Abbvie
9.7.1 Abbvie Profile
Table Abbvie Overview List
9.7.2 Abbvie Products & Services
9.7.3 Abbvie Company Dynamics & News
9.7.4 Abbvie Business Operation Conditions
Table Business Operation of Abbvie (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.8 Kyowa Hakko Kirin Pharma
9.8.1 Kyowa Hakko Kirin Pharma Profile
Table Kyowa Hakko Kirin Pharma Overview List
9.8.2 Kyowa Hakko Kirin Pharma Products & Services
9.8.3 Kyowa Hakko Kirin Pharma Company Dynamics & News
9.8.4 Kyowa Hakko Kirin Pharma Business Operation Conditions
Table Business Operation of Kyowa Hakko Kirin Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.9 Astellas Pharma
9.9.1 Astellas Pharma Profile
Table Astellas Pharma Overview List
9.9.2 Astellas Pharma Products & Services
9.9.3 Astellas Pharma Company Dynamics & News
9.9.4 Astellas Pharma Business Operation Conditions
Table Business Operation of Astellas Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.10 Desitin Arzneimittel
9.10.1 Desitin Arzneimittel Profile
Table Desitin Arzneimittel Overview List
9.10.2 Desitin Arzneimittel Products & Services
9.10.3 Desitin Arzneimittel Company Dynamics & News
9.10.4 Desitin Arzneimittel Business Operation Conditions
Table Business Operation of Desitin Arzneimittel (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.11 Endo Pharmaceuticals
9.11.1 Endo Pharmaceuticals Profile
Table Endo Pharmaceuticals Overview List
9.11.2 Endo Pharmaceuticals Products & Services
9.11.3 Endo Pharmaceuticals Company Dynamics & News
9.11.4 Endo Pharmaceuticals Business Operation Conditions
Table Business Operation of Endo Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.12 F.Hoffmann-La Roche
9.12.1 F.Hoffmann-La Roche Profile
Table F.Hoffmann-La Roche Overview List
9.12.2 F.Hoffmann-La Roche Products & Services
9.12.3 F.Hoffmann-La Roche Company Dynamics & News
9.12.4 F.Hoffmann-La Roche Business Operation Conditions
Table Business Operation of F.Hoffmann-La Roche (Sales Revenue, Cost, Gross Margin)
9.13 H.Lundbeck
9.13.1 H.Lundbeck Profile
Table H.Lundbeck Overview List
9.13.2 H.Lundbeck Products & Services
9.13.3 H.Lundbeck Company Dynamics & News
9.13.4 H.Lundbeck Business Operation Conditions
Table Business Operation of H.Lundbeck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.14 Valeant
9.14.1 Valeant Profile
Table Valeant Overview List
9.14.2 Valeant Products & Services
9.14.3 Valeant Company Dynamics & News
9.14.4 Valeant Business Operation Conditions
Table Business Operation of Valeant (Sales Revenue, Cost, Gross Margin)
9.15 Apokyn
9.15.1 Apokyn Profile
Table Apokyn Overview List
9.15.2 Apokyn Products & Services
9.15.3 Apokyn Company Dynamics & News
9.15.4 Apokyn Business Operation Conditions
Table Business Operation of Apokyn (Sales Revenue, Cost, Gross Margin)
9.16 Orion
9.16.1 Orion Profile
Table Orion Overview List
9.16.2 Orion Products & Services
9.16.3 Orion Company Dynamics & News
9.16.4 Orion Business Operation Conditions
Table Business Operation of Orion (Sales Revenue, Cost, Gross Margin)
9.17 Stada Arzneimittel
9.17.1 Stada Arzneimittel Profile
Table Stada Arzneimittel Overview List
9.17.2 Stada Arzneimittel Products & Services
9.17.3 Stada Arzneimittel Company Dynamics & News
9.17.4 Stada Arzneimittel Business Operation Conditions
Table Business Operation of Stada Arzneimittel (Sales Revenue, Cost, Gross Margin)
9.18 US WorldMeds
9.18.1 US WorldMeds Profile
Table US WorldMeds Overview List
9.18.2 US WorldMeds Products & Services
9.18.3 US WorldMeds Company Dynamics & News
9.18.4 US WorldMeds Business Operation Conditions
Table Business Operation of US WorldMeds (Sales Revenue, Cost, Gross Margin)
9.19 Valeant Pharmaceuticals
9.19.1 Valeant Pharmaceuticals Profile
Table Valeant Pharmaceuticals Overview List
9.19.2 Valeant Pharmaceuticals Products & Services
9.19.3 Valeant Pharmaceuticals Company Dynamics & News
9.19.4 Valeant Pharmaceuticals Business Operation Conditions
Table Business Operation of Valeant Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
PART 10 MARKET COMPETITION
10.1 Key Company Market Share
Table Global Parkinson's Disease Drug Sales Revenue 2015-2020E, by Companies, in USD Million
Table Global Parkinson's Disease Drug Sales Revenue Share, 2015-2020E, by Companies, in USD
Table Global Parkinson's Disease Drug Sales Volume by Companies, 2015-2020E (Volume)
Table Global Parkinson's Disease Drug Sales Volume Share by Companies, 2015-2020E (Volume)
10.2 Regional Market Concentration
Figure Europe Parkinson's Disease Drug Market Concentration Ratio in 2020E
Figure America Parkinson's Disease Drug Market Concentration Ratio in 2020E
Figure Asia Parkinson's Disease Drug Market Concentration Ratio in 2020E
Figure Oceania Parkinson's Disease Drug Market Concentration Ratio in 2020E
Figure Africa Parkinson's Disease Drug Market Concentration Ratio in 2020E
PART 11 CORONAVIRUS IMPACT ON Parkinson's Disease Drug INDUSTRY
11.1 Impact on Industry Upstream
11.2 Impact on Industry Downstream
11.3 Impact on Industry Channels
11.4 Impact on Industry Competition
11.5 Impact on Industry Obtain Employment
PART 12 Parkinson's Disease Drug INDUSTRY SUMMARY & CONCLUSION
List of Tables
Table Global Parkinson's Disease Drug Revenue by Type, 2015-2020 (Million USD)
Table Global Parkinson's Disease Drug Production Volume by Type, 2015-2020 (Volume)
Table Global Parkinson's Disease Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Table Global Parkinson's Disease Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Table Global Parkinson's Disease Drug Consumption Value by Region, 2015-2020 (Million USD)
Table Global Parkinson's Disease Drug Consumption Volume by Region, 2015-2020 (Volume)
Table Europe Parkinson's Disease Drug Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Europe Parkinson's Disease Drug Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Europe Parkinson's Disease Drug Revenue by Type, 2015-2020 (Million USD)
Table Europe Parkinson's Disease Drug Production Volume by Type, 2015-2020 (Volume)
Table Europe Parkinson's Disease Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Table Europe Parkinson's Disease Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Table Europe Parkinson's Disease Drug Consumption Value by Region, 2015-2020 (Million USD)
Table Europe Parkinson's Disease Drug Consumption Volume by Region, 2015-2020 (Volume)
Table America Parkinson's Disease Drug Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table America Parkinson's Disease Drug Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table America Parkinson's Disease Drug Revenue by Type, 2015-2020 (Million USD)
Table America Parkinson's Disease Drug Production Volume by Type, 2015-2020 (Volume)
Table America Parkinson's Disease Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Table America Parkinson's Disease Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Table America Parkinson's Disease Drug Consumption Value by Region, 2015-2020 (Million USD)
Table America Parkinson's Disease Drug Consumption Volume by Region, 2015-2020 (Volume)
Table Asia Parkinson's Disease Drug Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Asia Parkinson's Disease Drug Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Asia Parkinson's Disease Drug Revenue by Type, 2015-2020 (Million USD)
Table Asia Parkinson's Disease Drug Production Volume by Type, 2015-2020 (Volume)
Table Asia Parkinson's Disease Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Table Asia Parkinson's Disease Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Table Asia Parkinson's Disease Drug Consumption Value by Region, 2015-2020 (Million USD)
Table Asia Parkinson's Disease Drug Consumption Volume by Region, 2015-2020 (Volume)
Table Oceania Parkinson's Disease Drug Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Oceania Parkinson's Disease Drug Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Oceania Parkinson's Disease Drug Revenue by Type, 2015-2020 (Million USD)
Table Oceania Parkinson's Disease Drug Production Volume by Type, 2015-2020 (Volume)
Table Oceania Parkinson's Disease Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Table Oceania Parkinson's Disease Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Table Oceania Parkinson's Disease Drug Consumption Value by Region, 2015-2020 (Million USD)
Table Oceania Parkinson's Disease Drug Consumption Volume by Region, 2015-2020 (Volume)
Table Africa Parkinson's Disease Drug Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Africa Parkinson's Disease Drug Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Africa Parkinson's Disease Drug Revenue by Type, 2015-2020 (Million USD)
Table Africa Parkinson's Disease Drug Production Volume by Type, 2015-2020 (Volume)
Table Africa Parkinson's Disease Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Table Africa Parkinson's Disease Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Table Africa Parkinson's Disease Drug Consumption Value by Region, 2015-2020 (Million USD)
Table Africa Parkinson's Disease Drug Consumption Volume by Region, 2015-2020 (Volume)
Table Global Parkinson's Disease Drug Revenue by Type, 2020E-2025F (Million USD)
Table Global Parkinson's Disease Drug Production Volume by Type, 2020E-2025F (Volume)
Table Global Parkinson's Disease Drug Consumption Value by End-Use, 2020E-2025F (Million USD)
Table Global Parkinson's Disease Drug Consumption Volume by End-Use, 2020E-2025F (Volume)
Table Global Parkinson's Disease Drug Consumption Value by Region, 2020E-2025F (Million USD)
Table Global Parkinson's Disease Drug Consumption Volume by Region, 2020E-2025F (Volume)
Table Merck Overview List
Table Business Operation of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Akorn Overview List
Table Business Operation of Akorn (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GSK Overview List
Table Business Operation of GSK (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novartis Overview List
Table Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Boehringer Ingelheim Overview List
Table Business Operation of Boehringer Ingelheim (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Teva Pharmaceutical Overview List
Table Business Operation of Teva Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Abbvie Overview List
Table Business Operation of Abbvie (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Kyowa Hakko Kirin Pharma Overview List
Table Business Operation of Kyowa Hakko Kirin Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Astellas Pharma Overview List
Table Business Operation of Astellas Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Desitin Arzneimittel Overview List
Table Business Operation of Desitin Arzneimittel (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Endo Pharmaceuticals Overview List
Table Business Operation of Endo Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table F.Hoffmann-La Roche Overview List
Table Business Operation of F.Hoffmann-La Roche (Sales Revenue, Cost, Gross Margin)
Table H.Lundbeck Overview List
Table Business Operation of H.Lundbeck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Valeant Overview List
Table Business Operation of Valeant (Sales Revenue, Cost, Gross Margin)
Table Apokyn Overview List
Table Business Operation of Apokyn (Sales Revenue, Cost, Gross Margin)
Table Orion Overview List
Table Business Operation of Orion (Sales Revenue, Cost, Gross Margin)
Table Stada Arzneimittel Overview List
Table Business Operation of Stada Arzneimittel (Sales Revenue, Cost, Gross Margin)
Table US WorldMeds Overview List
Table Business Operation of US WorldMeds (Sales Revenue, Cost, Gross Margin)
Table Valeant Pharmaceuticals Overview List
Table Business Operation of Valeant Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
Table Global Parkinson's Disease Drug Sales Revenue 2015-2020E, by Companies, in USD Million
Table Global Parkinson's Disease Drug Sales Revenue Share, 2015-2020E, by Companies, in USD
Table Global Parkinson's Disease Drug Sales Volume by Companies, 2015-2020E (Volume)
Table Global Parkinson's Disease Drug Sales Volume Share by Companies, 2015-2020E (Volume)
List of Figures
Figure Europe Parkinson's Disease Drug Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Europe Parkinson's Disease Drug Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure America Parkinson's Disease Drug Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure America Parkinson's Disease Drug Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Asia Parkinson's Disease Drug Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure AsiaParkinson's Disease Drug Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Oceania Parkinson's Disease Drug Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Oceania Parkinson's Disease Drug Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Africa Parkinson's Disease Drug Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Africa Parkinson's Disease Drug Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Global Parkinson's Disease Drug Revenue Share by Type in 2020 (Million USD)
Figure Global Parkinson's Disease Drug Production Volume Share by Type in 2020 (Volume)
Figure Global Parkinson's Disease Drug Consumption Value Share by End-Use in 2020 (Million USD)
Figure Global Parkinson's Disease Drug Consumption Volume Share by End-Use in 2020 (Volume)
Figure Europe Parkinson's Disease Drug Revenue Share by Type in 2020 (Million USD)
Figure Europe Parkinson's Disease Drug Production Volume Share by Type in 2020 (Volume)
Figure Europe Parkinson's Disease Drug Consumption Value Share by End-Use in 2020 (Million USD)
Figure Europe Parkinson's Disease Drug Consumption Volume Share by End-Use in 2020 (Volume)
Figure America Parkinson's Disease Drug Revenue Share by Type in 2020 (Million USD)
Figure America Parkinson's Disease Drug Production Volume Share by Type in 2020 (Volume)
Figure America Parkinson's Disease Drug Consumption Value Share by End-Use in 2020 (Million USD)
Figure America
Global Parkinson's Disease Therapeutics Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 99
Parkinson's disease (PD), or simply Parkinson's, is a chronic degenerative disorder of The central nervous system that affects both The motor system and non-motor systems. The symptoms usually emerge slowly, and as The disease worsens, non-motor symptoms become more common. Early symptoms are tremor, rigidity, slowness of movement, and difficulty with walking. Problems may also arise with cognition, behaviour, sleep, and sensory systems. Parkinson's disease dementia becomes common in advanced st......
Global Amantadine Hydrochloride Market Insights, Forecast to 2029
Published: 29-Aug-2023 Price: US 4900 Onwards Pages: 109
Amantadine hydrochloride (CAS 665-66-7), C10H18ClN, the formula weight is 187.71, and its form is white crystal powder.
The global Amantadine Hydrochloride market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Amantadine hydrochloride is clinically effective in preventing and treating infections of various influenza A viruses. In the influenza epidemic period, this product is use......
Global Rasagiline Tablet Market Insights, Forecast to 2029
Published: 11-Aug-2023 Price: US 4900 Onwards Pages: 107
Rasagiline (Azilect, Azipron) is an irreversible inhibitor of monoamine oxidase-B used as a monotherapy to treat symptoms in early Parkinson's disease or as an adjunct therapy in more advanced cases.
The global Rasagiline Tablet market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The racemic form of the drug was invented by Aspro Nicholas in the early 1970s. Moussa B.H. Youdim identifi......
Global Parkinsons Disease Drug Market Insights, Forecast to 2029
Published: 02-Aug-2023 Price: US 4900 Onwards Pages: 113
Most people with Parkinson's disease eventually need a medication called levodopa. Levodopa is absorbed by the nerve cells in your brain and turned into the chemical dopamine, which is used to transmit messages between the parts of the brain and nerves that control movement.
The global Parkinsons Disease Drug market is projected to grow from US$ 5763.6 million in 2023 to US$ 7419.9 million by 2029, at a Compound Annual Growth Rate (CAGR) of 4.3% during the forecast period.
Global P......
Global Rasagiline Tablet Market Research Report 2023, Forecast to 2028
Published: 20-Mar-2023 Price: US 2680 Onwards Pages: 137
Rasagiline is used alone or with other medications (such as levodopa/carbidopa) to treat symptoms of Parkinson's disease. It can help improve symptoms such as shakiness, stiffness, and difficulty moving. It can also help reduce the amount of "off" time (periods of slow movement or stiffness).
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data fo......
Global Rasagiline Tablet Professional Survey Report 2023, Forecast to 2028
Published: 20-Mar-2023 Price: US 3280 Onwards Pages: 109
Rasagiline is used alone or with other medications (such as levodopa/carbidopa) to treat symptoms of Parkinson's disease. It can help improve symptoms such as shakiness, stiffness, and difficulty moving. It can also help reduce the amount of "off" time (periods of slow movement or stiffness).
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data fo......
Global Amantadine Hydrochloride Market Research Report 2023
Published: 09-Mar-2023 Price: US 2900 Onwards Pages: 98
Amantadine hydrochloride (CAS 665-66-7), C10H18ClN, the formula weight is 187.71, and its form is white crystal powder.
Highlights
The global Amantadine Hydrochloride market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
Amantadine hydrochloride is clinically effective......
Global Parkinson's Disease (PD) Drugs Professional Survey Report 2023, Forecast to 2028
Published: 21-Feb-2023 Price: US 3280 Onwards Pages: 133
Levodopa, the most effective Parkinson's disease medication, is a natural chemical that passes into your brain and is converted to dopamine. Levodopa is combined with carbidopa (Lodosyn), which protects levodopa from early conversion to dopamine outside your brain. This prevents or lessens side effects such as nausea.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market v......
Global Parkinson's Disease (PD) Drugs Market Research Report 2023, Forecast to 2028
Published: 21-Feb-2023 Price: US 2680 Onwards Pages: 159
Levodopa, the most effective Parkinson's disease medication, is a natural chemical that passes into your brain and is converted to dopamine. Levodopa is combined with carbidopa (Lodosyn), which protects levodopa from early conversion to dopamine outside your brain. This prevents or lessens side effects such as nausea.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market v......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs